Correlation Between Neoleukin Therapeutics and Revelation Biosciences
Can any of the company-specific risk be diversified away by investing in both Neoleukin Therapeutics and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neoleukin Therapeutics and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neoleukin Therapeutics and Revelation Biosciences, you can compare the effects of market volatilities on Neoleukin Therapeutics and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neoleukin Therapeutics with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neoleukin Therapeutics and Revelation Biosciences.
Diversification Opportunities for Neoleukin Therapeutics and Revelation Biosciences
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Neoleukin and Revelation is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Neoleukin Therapeutics and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and Neoleukin Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neoleukin Therapeutics are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of Neoleukin Therapeutics i.e., Neoleukin Therapeutics and Revelation Biosciences go up and down completely randomly.
Pair Corralation between Neoleukin Therapeutics and Revelation Biosciences
Given the investment horizon of 90 days Neoleukin Therapeutics is expected to generate 0.51 times more return on investment than Revelation Biosciences. However, Neoleukin Therapeutics is 1.96 times less risky than Revelation Biosciences. It trades about -0.07 of its potential returns per unit of risk. Revelation Biosciences is currently generating about -0.06 per unit of risk. If you would invest 79.00 in Neoleukin Therapeutics on August 31, 2024 and sell it today you would lose (10.00) from holding Neoleukin Therapeutics or give up 12.66% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 8.58% |
| Values | Daily Returns |
Neoleukin Therapeutics vs. Revelation Biosciences
Performance |
| Timeline |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Revelation Biosciences |
Neoleukin Therapeutics and Revelation Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neoleukin Therapeutics and Revelation Biosciences
The main advantage of trading using opposite Neoleukin Therapeutics and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neoleukin Therapeutics position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
| Revelation Biosciences vs. Cue Biopharma | Revelation Biosciences vs. Eliem Therapeutics | Revelation Biosciences vs. Inhibrx | Revelation Biosciences vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |